Cargando…
Antibody–Drug Conjugates as an Emerging Therapy in Oncodermatology
SIMPLE SUMMARY: Currently, the therapeutic arsenal to fight cancers is extensive. Among these, antibody–drug conjugates (ADCs) consist in an antibody linked to a cytotoxic agent, allowing a specific delivery to tumor cells. ADCs are an emerging class of therapeutics, with twelve FDA- and EMA-approve...
Autores principales: | Esnault, Clara, Schrama, David, Houben, Roland, Guyétant, Serge, Desgranges, Audrey, Martin, Camille, Berthon, Patricia, Viaud-Massuard, Marie-Claude, Touzé, Antoine, Kervarrec, Thibault, Samimi, Mahtab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833781/ https://www.ncbi.nlm.nih.gov/pubmed/35159045 http://dx.doi.org/10.3390/cancers14030778 |
Ejemplares similares
-
Histogenesis of Merkel Cell Carcinoma: A Comprehensive Review
por: Kervarrec, Thibault, et al.
Publicado: (2019) -
Merkel Cell Polyomavirus T Antigens Induce Merkel Cell-Like Differentiation in GLI1-Expressing Epithelial Cells
por: Kervarrec, Thibault, et al.
Publicado: (2020) -
Impact of Maleimide
Disubstitution on Chemical and
Biological Characteristics of HER2 Antibody–Drug Conjugates
por: Feuillâtre, Ofelia, et al.
Publicado: (2020) -
Uses of Polypodium leucotomos Extract in Oncodermatology
por: Calzari, Paolo, et al.
Publicado: (2023) -
Merkel Cell Polyomavirus: Infection, Genome, Transcripts and Its Role in Development of Merkel Cell Carcinoma
por: Houben, Roland, et al.
Publicado: (2023)